ANI PHARMACEUTICALS, INC (ANIP) Operating margin 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) operating margin by fiscal year — reported operating income divided by reported revenue.
12.6%FY2025 · since FY2016: 15.6% → 12.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 12.6% | +12.5 pp |
| FY2024 | 0.1% | -9.6 pp |
| FY2023 | 9.6% | +20.8 pp |
| FY2022 | -11.2% | +7.3 pp |
| FY2021 | -18.4% | -10.7 pp |
| FY2020 | -7.7% | -15.6 pp |
| FY2019 | 7.9% | -9.6 pp |
| FY2018 | 17.5% | +1.5 pp |
| FY2017 | 16.0% | +0.4 pp |
| FY2016 | 15.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIP financial trends
ANIP RevenueANIP Net incomeANIP Net marginANIP Gross profitANIP Gross marginANIP Operating incomeANIP Operating cash flowANIP Free cash flowANIP Capital expendituresANIP Return on equityANIP Stock buybacksANIP Dividends paidANIP Total assetsANIP Total liabilitiesANIP Shareholders’ equityANIP overview →